Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK

INTRODUCTION: Large numbers of patients with type 2 diabetes receive treatment with a sodium-glucose co-transporter-2 inhibitor (SGLT2i). We investigated whether the cardiorenal preventative effects found in clinical trials are also seen in clinical practice where patient characteristics and adheren...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez Perez, Antonio, Vizcaya, David, Sáez, Maria E, Lind, Marcus, Garcia Rodriguez, Luis A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology/Health services research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814995/
https://www.ncbi.nlm.nih.gov/pubmed/36596641
http://dx.doi.org/10.1136/bmjdrc-2022-003072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814995/
https://www.ncbi.nlm.nih.gov/pubmed/36596641
http://dx.doi.org/10.1136/bmjdrc-2022-003072

Ejemplares similares